Novartis launches new cell and gene therapy at Dubai’s 2020 Expo

UAE- Novartis, a Swiss pharmaceutical multinational that is currently involved in cell and gene therapy innovation, has been able to assist five young patients from the UAE who were facing the threat of progressive blindness. Dr Ahmed Baly, chief scientific officer at Novartis Gulf, during a presentation on cutting-edge cell and gene therapy innovations titled ‘Remaining Medicine’ at Expo 2020 Dubai said: “These five young individuals would have suffered progressive loss of sight. Our one-time treatment based on cell and gene therapy was successfully able to prevent further deterioration of…

Read More

UCB to license its AI technology for fracture identification to ImageBiopsy Lab

BELGIUM – UCB has announced a strategic out-licensing of its AI-based fracture identification technology, BoneBot, to ImageBiopsy Lab, for further development and bring it to clinical practice by 2023. The radiology AI solution will screen CT scans for “silent” or asymptomatic fractures in the spine, which would otherwise go unnoticed and unreported. The BoneBot digital health tool uses machine learning to detect silent or asymptomatic fractures in the spine’s vertebrae, a feature of the bone-wasting disease osteoporosis that can go undetected in more than two-thirds of cases. Catching these fractures…

Read More

Medtronic to invest US$50 million in Open Innovation Platform for healthcare in APAC

INDIA – Medtronic plc, a global leader in healthcare technology, has announced the launch of the Medtronic Open Innovation Platform (OIP) for the Asia Pacific to advance the future of healthcare technologies. The OIP will bring strategic collaboration in healthcare technologies among various stakeholders across the healthcare ecosystem through capability development, partnerships, and business organizations networking in medical technology and digital health in APAC, with Singapore as the epicenter. This first-of-its-kind platform will enable Medtronic to explore and advance partnership opportunities that can help it leverage artificial intelligence (AI) and…

Read More

Roche ties up with Ibex Medical Analytics to develop AI-based cancer detection

SWITZERLAND – Roche has announced a collaboration with Ibex Medical Analytics, an Israeli artificial intelligence-based cancer diagnostics startup to develop artificial intelligence assisted cancer detection device to help diagnose early cancer detection. The companies will collaborate to create an embedded image analysis workflow for pathologists to use the cloud version of Roche’s uPath enterprise software to access Ibex’s AI algorithms, insights, and decision support tools. The US Food and Drug Administration recently granted Breakthrough Device Designation to Ibex’s Galen platform, which is CE marked in Europe for breast and prostate…

Read More

Machine learning revolutionizes mental health assessment

UNITED KINGDOM – A groundbreaking study published in the journal GigaScience has found that Artificial Intelligence (AI) can perform high-quality mental health assessments, potentially improving the future of diagnostics for mental health disorders. The study, led by Denis Engemann of Inria, revealed that machine learning from large population cohorts can produce “proxy measures” for brain-related conditions without requiring a specialist’s mental health assessment. For their study, the researchers used the UK Biobank, one of the most comprehensive and large biomedical databases on the planet, which contains extensive and health-related data…

Read More

Boehringer launches state-of-the-art biopharma production facility in Vienna

GERMANY – German family-owned biopharma major Boehringer Ingelheim has inaugurated a state-of-the-art biologics facility in Vienna, Austria heralding the single-largest investment in the company’s history. The Large-Scale Cell Culture (LSCC) is one of the most advanced in its own league, boasting a high degree of digitalization and automation through smart technologies and artificial intelligence (AI) applications. The facility boasts a total of 48 stainless-steel bioreactors at various scales, boasts a production capacity of 185,000 liters, exceeding its original planned capacity of 150,000 liters. The facility, which increased mammalian large scale…

Read More

Big win for Paige Prostate as FDA grants approval for use in digital pathology

USA- The FDA has approved the sale of software, Paige Prostate, designed to assist pathologists in the detection of prostate cancer. Paige prostate is the first artificial intelligence (AI)-based pathology product to be approved by the FDA, and it is used in conjunction with the company’s previously approved FullFocus digital pathology viewer designed to identify areas on a prostate biopsy that are most likely to be cancerous. The FDA granted approval based on the results of a study in which 6 pathologists examined 527 digitally scanned prostate biopsy slides. There…

Read More

AI company Macro-Eyes secures US$2m funding to expand in two additional countries

SIERRA LEONE – Macro-Eyes, a machine learning company increasing access to care, has received US$2.1 million in funding to expand the deployment of STRIATA in collaboration with the Ministry of Health and Sanitation (MoHS) in Sierra Leone and to expand into two additional countries. This additional funding will support two years of STRIATA deployment in Sierra Leone. Strategic rollout and preliminary use cases are being guided by the MoHS through the Intelligent Health Systems Technical Working Group facilitated by Macro-Eyes. The expansion in Sierra Leone will focus on integrating the…

Read More

Healthcare sector quadruple aim goals boosts medical imaging & informatics market

WORLD – Based on a recent analysis by Frost & Sullivan, Global Medical Imaging & Informatics Outlook, 2021, the market opportunity is estimated to hit US$37.10 billion in 2021 from US$33.90 billion in 2020, registering growth at 9.4% under an aspirational scenario. This is a trend attributed to the healthcare sector’s emphasis on meeting its Quadruple Aim goal of cost reduction, clinical outcomes, enhance the patient and caregiver experience, and improve the work-life of healthcare providers. With the onset of the pandemic, a focus on efficiency and productivity will attain…

Read More

Medtronic integrates robotic-assisted surgery system program in hospitals across Chile

US – Medtronic, an American-Irish registered medical device company, has integrated hugo robotic-assisted surgery (RAS) system at Hospital Clinico de la Red de Salud UC CHRISTUS in Santiago, Chile, to support the teaching institution’s new robotic surgery program. UC CHRISTUS is the latest institution to join Medtronic’s Partners in Possibility Program, a group of pioneering hospitals that will be among the first in the world to use the Hugo RAS system in support of the Hugo system patient registry. The Hugo RAS system combines the precision of wristed instruments with…

Read More